Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind active-controlled study of salmeterol + fluticasone powder for inhalation in adults with bronchial asthma
CTR20140916Phase 2Terminated
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Jan 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of salmeterol, fluticasone propionate in asthma, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Jan 2015; status: terminated.
02
Drugs
salmeterolfluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20140916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140916.